BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 23432410)

  • 1. Effective elimination of cancer stem cells by magnetic hyperthermia.
    Sadhukha T; Niu L; Wiedmann TS; Panyam J
    Mol Pharm; 2013 Apr; 10(4):1432-41. PubMed ID: 23432410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer hyperthermia using magnetic nanoparticles.
    Kobayashi T
    Biotechnol J; 2011 Nov; 6(11):1342-7. PubMed ID: 22069094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of breast cancer stem cells by gold nanorods mediated plasmonic hyperthermia.
    Xu Y; Wang J; Li X; Liu Y; Dai L; Wu X; Chen C
    Biomaterials; 2014 May; 35(16):4667-77. PubMed ID: 24630839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex of TNF-α and Modified Fe
    Teo P; Wang X; Chen B; Zhang H; Yang X; Huang Y; Tang J
    Cancer Biother Radiopharm; 2017 Dec; 32(10):379-386. PubMed ID: 29265918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using thermal energy produced by irradiation of Mn-Zn ferrite magnetic nanoparticles (MZF-NPs) for heat-inducible gene expression.
    Tang QS; Zhang DS; Cong XM; Wan ML; Jin LQ
    Biomaterials; 2008 Jun; 29(17):2673-9. PubMed ID: 18396332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted destruction of cancer stem cells using multifunctional magnetic nanoparticles that enable combined hyperthermia and chemotherapy.
    Liu D; Hong Y; Li Y; Hu C; Yip TC; Yu WK; Zhu Y; Fong CC; Wang W; Au SK; Wang S; Yang M
    Theranostics; 2020; 10(3):1181-1196. PubMed ID: 31938059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.
    Li FR; Yan WH; Guo YH; Qi H; Zhou HX
    Int J Hyperthermia; 2009 Aug; 25(5):383-91. PubMed ID: 19391033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
    Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
    Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facile synthesis of water-stable magnetite nanoparticles for clinical MRI and magnetic hyperthermia applications.
    Maity D; Chandrasekharan P; Yang CT; Chuang KH; Shuter B; Xue JM; Ding J; Feng SS
    Nanomedicine (Lond); 2010 Dec; 5(10):1571-84. PubMed ID: 21143034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A facile microwave synthetic route for ferrite nanoparticles with direct impact in magnetic particle hyperthermia.
    Makridis A; Chatzitheodorou I; Topouridou K; Yavropoulou MP; Angelakeris M; Dendrinou-Samara C
    Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():663-70. PubMed ID: 27040263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetically triggered dual functional nanoparticles for resistance-free apoptotic hyperthermia.
    Yoo D; Jeong H; Noh SH; Lee JH; Cheon J
    Angew Chem Int Ed Engl; 2013 Dec; 52(49):13047-51. PubMed ID: 24281889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor local chemohyperthermia using docetaxel-embedded magnetoliposomes: Interaction of chemotherapy and hyperthermia.
    Yoshida M; Sato M; Yamamoto Y; Maehara T; Naohara T; Aono H; Sugishita H; Sato K; Watanabe Y
    J Gastroenterol Hepatol; 2012 Feb; 27(2):406-11. PubMed ID: 22098478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer effect and feasibility study of hyperthermia treatment of pancreatic cancer using magnetic nanoparticles.
    Wang L; Dong J; Ouyang W; Wang X; Tang J
    Oncol Rep; 2012 Mar; 27(3):719-26. PubMed ID: 22134718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shape-controlled fabrication of magnetite silver hybrid nanoparticles with high performance magnetic hyperthermia.
    Ding Q; Liu D; Guo D; Yang F; Pang X; Che R; Zhou N; Xie J; Sun J; Huang Z; Gu N
    Biomaterials; 2017 Apr; 124():35-46. PubMed ID: 28187393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells.
    Taratula O; Dani RK; Schumann C; Xu H; Wang A; Song H; Dhagat P; Taratula O
    Int J Pharm; 2013 Dec; 458(1):169-80. PubMed ID: 24091153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer.
    Mu C; Wu X; Zhou X; Wolfram J; Shen J; Zhang D; Mai J; Xia X; Holder AM; Ferrari M; Liu X; Shen H
    Clin Cancer Res; 2018 Oct; 24(19):4900-4912. PubMed ID: 29921732
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
    Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
    Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic mesoporous silica spheres for hyperthermia therapy.
    Martín-Saavedra FM; Ruíz-Hernández E; Boré A; Arcos D; Vallet-Regí M; Vilaboa N
    Acta Biomater; 2010 Dec; 6(12):4522-31. PubMed ID: 20601238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local moderate magnetically induced hyperthermia using an implant formed in situ in a mouse tumor model.
    Le Renard PE; Buchegger F; Petri-Fink A; Bosman F; Rüfenacht D; Hofmann H; Doelker E; Jordan O
    Int J Hyperthermia; 2009 May; 25(3):229-39. PubMed ID: 19437238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat-Generating Iron Oxide Multigranule Nanoclusters for Enhancing Hyperthermic Efficacy in Tumor Treatment.
    Jeon S; Park BC; Lim S; Yoon HY; Jeon YS; Kim BS; Kim YK; Kim K
    ACS Appl Mater Interfaces; 2020 Jul; 12(30):33483-33491. PubMed ID: 32614594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.